Our passion is transforming the data we collect into engaging insights.
We are a global provider of industry leading healthcare and pharmaceutical market research solutions backed by our Leave No Stone Unturned Guarantee.
A market research panel exclusively for healthcare professionals.
Industry Expertise
Since 2003, we have conducted market research in a variety of health-related areas amassing deep expertise and proprietary norms within the pharmaceutical and healthcare industry.
Superior Sample
Fueled by our proprietary market research panel of healthcare professionals, our in-house field team consistently delivers more target respondents and larger sample sizes.
Engaging Insights
Recognized in the health and pharmaceutical market research industry for our visually intuitive and engaging story-based reports, we move the boardroom conversation from understanding to taking action.
A market research panel exclusively for healthcare professionals.
Topical Polls and Industry Trends
The Performance Of Patient Support Providers During The Pandemic
We surveyed 152 physicians in the U.S. to gauge their opinions on Patient Support Program (PSPs) providers during the pandemic. Physicians surveyed include GPs, Hematologists, Medical Oncologists, Rheumatologists, Pulmonologists, Endocrinologists and Infectious Disease Specialists. Overall perceptions of PSPs compared to before the pandemic have generally improved – especially in terms of responsiveness and the expertise of individuals working on PSPs.
Pandemic Impact On Patient Support Programs
PSPs play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible.
PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process. For the most part, physicians acknowledge that PSP providers have adjusted well to the new reality brought forth by COVID-19. About a third even think that PSP providers have improved their performance since the onset of the pandemic.
How Patient Support Program Providers Adjusted To The Pandemic
Physicians feel positive about how Patient Support Programs (PSPs) have evolved in the past two years – especially in terms of responsiveness and the expertise of individuals working on PSPs. The main unmet needs at this time remain the range of service hours and the availabilityof nurses remotely (either by phone or virtually). Many specialists believe that biosimilar PSP providers have struggled more than originator drug PSPs since the onset of the pandemic – mainly because of they do not have as many employees and offer a smaller range of services.
Your answers,
our guarantee.